Analytical Chemistry · 2022 · 16 citations · 47 references
Life SciencesBiochemistryBioengineeringBiomaterialsClinical BiochemistryProteomicsBottom-up ProteomicsClinical ProteomicsMass SpectrometryMass Spectrometry-based ProteomicsProtein AdsorptionProteomic ProfilingMass Spectrometry ProteomicsMass Spectrometry-based Protein IdentificationMethod Detection LimitProfilingProtein BiomarkersProtein Mass SpectrometryProteomic IdentificationSurface Disulfide Engineering
Blood is one of the most important clinical samples for protein biomarker discovery, as it provides rich physiological and pathological information and is easy to obtain with low invasiveness. However, the discovery of protein biomarkers in the blood by mass spectrometry (MS)-based proteomic strategies has been shown to be highly challenging due to the particularly large concentration range of proteins and the strong interference by the high-abundant proteins in the blood. Therefore, developing sensitive methods for low-abundant biomarker protein identification is a key issue that has received great attention. Here, we report the synthesis and characterization of surface-functionalized magnetic molybdenum disulfide (MoS2) for the large-scale adsorption of low-abundant plasma proteins and deep profiling by MS. MoS2 nanomaterials resulted in the coverage of more than 3400 proteins (including a single-peptide hit) in a single LC–MS analysis without peptide prefractionation using pooled plasma samples, which were five times more than those obtained by the direct analysis of the plasma proteome. A detection limit in the low ng L–1 range was obtained, which is rare compared with previous reports.
47
Proteomic and Metabolomic Characterization of COVID-19 Patient Sera
Bo Shen, Xiao Yi, Yaoting Sun et al. · Cell · 2020 · 1.6K citations · Full text
Undulating changes in human plasma proteome profiles across the lifespan
Benoit Lehallier, David Gate, Nicholas Schaum et al. · Nature Medicine · 2019 · 986 citations · Full text
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
Ying Jiang, Aihua Sun, Yang Zhao et al. · Nature · 2019 · 980 citations